Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Citius Oncology Inc (NASDAQ: CTOR) was $1.28 for the day, up 4.07% from the previous closing price of $1.23. In other words, the price has increased by $4.07 from its previous closing price. On the day, 0.75 million shares were traded.
Ratios:
Our analysis of CTOR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.05 and its Current Ratio is at 0.36. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on November 27, 2024, initiated with a Buy rating and assigned the stock a target price of $3.
Stock Price History:
Over the past 52 weeks, CTOR has reached a high of $49.00, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is 53.48%, while the 200-Day Moving Average is calculated to be 15.02%.
Shares Statistics:
A total of 71.55M shares are outstanding, with a floating share count of 3.52M. Insiders hold about 95.08% of the company’s shares, while institutions hold 0.15% stake in the company.
